182 related articles for article (PubMed ID: 29187484)
1. Phase II Study of Concurrent Chemoradiotheapy Using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma (KGROG0501): Final Results.
Niibe Y; Onda T; Matsuo K; Inoue Y; Hayakawa K
Anticancer Res; 2017 Dec; 37(12):6983-6988. PubMed ID: 29187484
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.
Niibe Y; Tsunoda S; Jobo T; Imai M; Matsuo K; Matsunaga K; Unno N; Hayakawa K
Eur J Gynaecol Oncol; 2008; 29(3):222-4. PubMed ID: 18592783
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma: Kitasato Gynecologic Radiation Oncology Group (KGROG 0501).
Niibe Y; Hayakawa K; Tsunoda S; Kanai T; Imai M; Arai M; Arai T; Kawaguchi M; Jobo T; Hamada Y; Yago K; Unno N;
Jpn J Clin Oncol; 2007 Jan; 37(1):70-2. PubMed ID: 17204507
[TBL] [Abstract][Full Text] [Related]
4. A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study.
Yokoyama Y; Takano T; Nakahara K; Shoji T; Sato H; Yamada H; Yaegashi N; Okamura K; Kurachi H; Sugiyama T; Tanaka T; Sato A; Tase T; Mizunuma H
Oncol Rep; 2008 Jun; 19(6):1551-6. PubMed ID: 18497964
[TBL] [Abstract][Full Text] [Related]
5. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
7. Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial.
Köhler C; Mustea A; Marnitz S; Schneider A; Chiantera V; Ulrich U; Scharf JP; Martus P; Vieira MA; Tsunoda A
Am J Obstet Gynecol; 2015 Oct; 213(4):503.e1-7. PubMed ID: 25986030
[TBL] [Abstract][Full Text] [Related]
8. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Chemoradiotherapy in Locally Advanced Bulky Squamous Cell Carcinoma of the Uterine Cervix.
Nakao Y; Hashiguchi M; Nishiyama S; Aihara S; Iwasaka T; Yokoyama M
Int J Gynecol Cancer; 2017 Nov; 27(9):1943-1948. PubMed ID: 28786876
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of alternating chemoradiotherapy by conformal radiotherapy combined with intracavitary brachytherapy for high-risk cervical cancer.
Hirata K; Kodaira T; Tomita N; Ohshima Y; Ito J; Tachibana H; Nakanishi T; Fuwa N
Jpn J Clin Oncol; 2014 Jun; 44(6):556-63. PubMed ID: 24755546
[TBL] [Abstract][Full Text] [Related]
13. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
[TBL] [Abstract][Full Text] [Related]
14. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
Marnitz S; Martus P; Köhler C; Stromberger C; Asse E; Mallmann P; Schmidberger H; Affonso Júnior RJ; Nunes JS; Sehouli J; Budach V
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):243-53. PubMed ID: 26853333
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix.
Yuan G; Wu L; Huang M; Li N; An J
Radiat Oncol; 2014 Feb; 9():55. PubMed ID: 24533532
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
Schefter TE; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Gaffney DK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1179-84. PubMed ID: 22342094
[TBL] [Abstract][Full Text] [Related]
17. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
18. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
